Coronary angiography after cardiac arrest without ST-elevation myocardial infarction: a network meta-analysis

Sebastian Heyne1, Sascha Macherey1, Max M Meertens1

  • 1University of Cologne, Faculty of Medicine and University Hospital Cologne, Clinic III for Internal Medicine, Kerpener Str. 62, 50937 Cologne, Germany.

European Heart Journal
|October 27, 2022
PubMed

Insights

Early coronary angiography (CAG) after out-of-hospital cardiac arrest without ST-elevation myocardial infarction (NSTE-OHCA) is not routinely supported by randomized trials. Non-randomized studies suggest benefit, but are prone to bias.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Critical Care Medicine

Background:

  • Early coronary angiography (CAG) is debated for patients with out-of-hospital cardiac arrest without ST-elevation myocardial infarction (NSTE-OHCA).
  • Previous findings suggesting early CAG superiority stem from non-randomized studies (NRS).

Purpose of the Study:

  • To assess the effect of early versus selective CAG in NSTE-OHCA patients.
  • To evaluate survival and neurological outcomes based on study design.

Main Methods:

  • Network meta-analysis of 16 studies (6 RCTs, 10 NRS) comparing early vs. selective CAG.
  • Systematic literature search across EMBASE, MEDLINE, and Web of Science.
  • Random effects models (DerSimonian-Laird and Bayesian) were employed.

Main Results:

  • Overall analysis of all studies showed increased survival with early CAG (OR: 1.40, 95% CI: 1.12-1.76).
  • Subgroup analysis of RCTs found no significant survival benefit for early CAG (OR: 0.89, 95% CI: 0.73-1.10).
  • NRS indicated significantly increased survival with late CAG compared to early CAG (OR: 4.20, 95% CI: 1.22-20.91).

Conclusions:

  • The perceived benefit of early CAG in NSTE-OHCA is likely due to bias in non-randomized studies.
  • Meta-analysis of RCTs does not support routine early CAG for NSTE-OHCA patients.
Abstract

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
20
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
22
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
56
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
23
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
35
Imaging Studies for Cardiovascular System V: CT01:28

Imaging Studies for Cardiovascular System V: CT

Cardiac computed tomography (CT) scanning is an advanced cardiac imaging technique that utilizes CT technology, with or without intravenous (IV) contrast, to produce accurate cross-sectional virtual slices of specific areas of the heart, coronary circulation, and major blood vessels such as the aorta, pulmonary veins, and arteries. The computer processes these slices to generate three-dimensional images. Multidetector CT (MDCT) is a rapid form of CT scanning that captures multiple slices...
58